Epigral Limited has released its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a consolidated revenue from operations of ₹2,527.18 crore for the full fiscal year. Amid its strategic focus on the Chloro Alkali sector, the Board has recommended a final dividend of ₹5.00 per equity share, reflecting a 50% payout on the face value of the shares.
Annual Financial Performance
For the financial year ended March 31, 2026, Epigral Limited achieved a consolidated revenue of ₹2,527.18 crore. The company reported a net profit of ₹331.97 crore for the year. The fourth quarter results, specifically for the period of January to March 2026, showed strong operational performance with revenues of ₹736.16 crore and a quarterly net profit of ₹80.95 crore.
Strategic Dividend Recommendation
Demonstrating its commitment to creating shareholder value, the Board of Directors has recommended a final dividend of ₹5.00 per share. This dividend, which represents a 50% return on the face value of ₹10/- per share, is subject to the necessary approvals and will be distributed in accordance with the relevant statutory provisions.
Investment and Operational Updates
Epigral continues to solidify its presence in the Chloro Alkali business. During the year, the company took significant steps to secure its energy requirements by entering into a Share Subscription and Shareholders’ Agreement. This involves an investment in a Power Producer dedicated to the development of a 19.80 MW Wind-Solar Hybrid power plant. Furthermore, the company has entered into a long-term Energy Supply Agreement to purchase at least 51% of the power generated from this source over the next 25 years, ensuring sustainable and cost-efficient energy for its manufacturing operations.
Audit and Governance
The financial statements for the year were audited by M/s. S R B C & CO LLP, who have issued an unmodified opinion on both the standalone and consolidated results. The company maintains its focus on internal efficiencies and regulatory compliance as it progresses into the new fiscal year.
Source: BSE
